Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors


    9th Annual Pharma Regulatory Summit 2026

    View: 16

    Website https://virtueinsight.com/events/pharma-regulatory-summit-2026-2/ | Want to Edit it Edit Freely

    Category pharma

    Deadline: March 23, 2026 | Date: March 24, 2026

    Venue/Country: Mumbai, India

    Updated: 2026-01-21 15:18:40 (GMT+9)

    Call For Papers - CFP

    9TH ANNUAL PHARMA REGULATORY SUMMIT 2026

    “Driving Regulatory Excellence for a Changing Pharma Landscape”

    24th March 2026, Hotel Kohinoor Continental, Mumbai, India

    The 9th Annual Pharma Regulatory Summit 2026 congregates foremost global pharmaceutical industry professionals and regulators to share their insights on technologies, approaches, and solutions that will drive innovation and quality for the medicines delivered to patients worldwide. This interactional setting with expert-led regulatory and industry presentations will ensure pharmaceutical industry professionals to develop and apply ingenious solutions in today’s Indian pharma ecosystem.

    Sponsor / Delegate Registration E-mail - kavithaatvirtueinsight.co.in or M: +91 9361957193

    DELEGATE REGISTRATION :

    Super Early Bird Price (Valid until 06th Feb 2026) – INR 10,000+ GST (18%) per delegate

    Early Bird Price (Valid from 07th Feb - 13th March 2026) – INR 12,000+ GST (18%) per delegate

    Standard Price – INR 15,000 + GST (18%) per delegate

    SPONSORS:

    Conference Sponsor – Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) / paid Speaker Slot / create brand awareness, you can simply email or call your interest and queries.

    KEY SPEAKERS:

    MAYUR PARMAR, Drugs Inspector (Deputy Collector, Gujarat Government), FDA

    NAGENDRAN IRUKULAPATI, Sr. Vice President – Global Regulatory Affairs, Aurobindo Pharma

    RAMANARAYANA PARHI, Vice President & CIO, Alkem Laboratories

    JULIET REBELLO, Director - Clinical Dev Strategy & Medical Writing,Cipla

    ANJU AGARWAL, Director Global Patient Safety, Advanz Pharma

    AMITA BHAVE, Director Regulatory Affairs, AstraZeneca

    MILIND ANTANI, Leader, Pharma and Healthcare, Nishith Desai Associates

    PALLAVI TRIVEDI, Associate Director – Diabeties and Obesity, Global Business Services (GBS), Novo Nordisk

    SANTOSH TAUR, Director Medical Affairs, Vaccines, Rare Diseases and Digital, Pfizer

    AKSHAYA ODAK, Head Regulatory Affairs (Biotech), Lupin

    PROTITI BAGCHI, Associate Director- Digital Transformation, GSK

    SUCHITA MORE, Director Medical Modernization, Asia Pacific & Japan, Merck Sharp & Dohme

    AMARNATH SUGUMARAN, Director - Medical Affairs, Cipla

    SHUVANKAR BALLAV, Head, Regulatory Affairs - Advanced Biotech Lab (ABL), Ipca Laboratories

    PANKAJ CHAUDHARI, Head - Global Regulatory Affairs (Biosimilar), Abbott

    AMOL CHOULWAR, Group Leader - Regulatory Affairs (Biosimilar Peptides New Drugs Vaccines),Cipla

    MINOO BIJU, Head-Regulatory Affairs, Piramal Pharma Solutions

    MARTINA GOMES, Head, Reg Affairs – CH, Bayer

    PRIYA CHATTERJEE, Head Regulatory Affairs - South Asia, Bayer

    SHIRAZ KANDAWALLA, Head – Regulatory, Quality & Safety – India, Ferring Pharma

    SADANAND KULKARNI, Head - Medical, Regulatory, Vigilance & Quality (South Asia), Fresenius Kabi

    JAYASHRI PRAMOD, Regulatory Principal Specialist, Novo Nordisk

    SUSHMITA KUSWA, Head Medical & Regulatory Affairs, Piramal

    OMPRAKASH S. SADHWANI, Former Joint Commissioner & Controlling Authority, FDA (Maharashtra State)

    RUCHIR SHAH, Head Medical Devices Category, Regulatory & Safety Manager, Reckitt Benckiser

    RASHMI HEGDE, Former Executive Vice President – Medical, GSK

    NEELU GOEL, Regulatory Affairs - Head Business Continuity & Compliance, Sun Pharma

    PRIYA PRASAD, General Manager – PV, Lupin

    KAVITA LAMROR, Partner, RWE & Digital Transformation, Maxis Clinical Sciences

    Plus more joining soon

    FOCUS AREAS:

    • Digital Transformation

    • Biologics & Biosimilars

    • Regulatory Writing & Submissions

    • Clinical Trials/DCT

    • Patient Safety

    • RWE/RWD

    • New Drugs

    • Generic Groups

    • Vendor Management

    • Medical Devices

    WHO SHOULD ATTEND AND WHO YOU’LL MEET:

    This conference is specifically designed for pharma, biotech, CRO’s, Government and Regulators, Hospitals/Trial Sites, Technology / Solution Providers from following areas;

    Regulatory Affairs, Clinical Trials / Clinical Data, Biologics & Biosimilars, Medical Devices, Regulatory Writing/Medical Writing/Publishing/Information/Submissions, Document and eRecords Management, Clinical Trials Management/Data, Outsourcing /Vendor Management, Quality Assurance/Quality Control, Technology AI, ML, Blockchain, Big Data, Supply Chain Management , Government- Department of Health, Vaccines R&D / Innovation, Consultants

    Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, and meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies at the high-level conference.


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.